343 related articles for article (PubMed ID: 1320689)
1. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
[TBL] [Abstract][Full Text] [Related]
2. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975
[TBL] [Abstract][Full Text] [Related]
3. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
Werling LL; Puttfarcken PS; Cox BM
Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
Nishino K; Su YF; Wong CS; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
[TBL] [Abstract][Full Text] [Related]
6. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors.
Wong CS; Su YF; Chang KJ; Watkins WD
Anesthesiology; 1992 Oct; 77(4):691-9. PubMed ID: 1329580
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Hom DS; Loh HH
J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
[TBL] [Abstract][Full Text] [Related]
10. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
Roerig SC; Loh HH; Law PY
Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
[TBL] [Abstract][Full Text] [Related]
11. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
Ramkumar V; Stiles GL
J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
[TBL] [Abstract][Full Text] [Related]
13. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
14. 3H-naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding.
Brown GP; Pasternak GW
J Pharmacol Exp Ther; 1998 Jul; 286(1):376-81. PubMed ID: 9655882
[TBL] [Abstract][Full Text] [Related]
15. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
[TBL] [Abstract][Full Text] [Related]
16. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-adrenergic receptor-linked guanine nucleotide-binding protein in muscle and kidney epithelial cells.
Terman BI; Slivka SR; Hughes RJ; Insel PA
Mol Pharmacol; 1987 Jan; 31(1):12-20. PubMed ID: 3027523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
